Biotech · Private company
Veralox Therapeutics
Track this companyFree. Adds Veralox Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- VLX-1005Phase 2 · Thrombocytopenia, ImmuneClinicalTrials.gov · fetched Nov 12, 2026
- ArgatrobanPhase 1 · Heparin-induced ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- VLX-1005Phase 1 · Heparin-induced ThrombocytopeniaClinicalTrials.gov · fetched Nov 12, 2026
- VLX-1005Phase 1 · Safety and Tolerability in Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced ThrombocytopeniaPHASE2 · TERMINATED · started Sep 26, 2023ClinicalTrials.gov NCT05785819 · fetched Nov 12, 2026
- A Phase I Study of the Co-administration of VLX-1005 and Argatroban in Healthy Human SubjectsPHASE1 · COMPLETED · started Mar 7, 2022ClinicalTrials.gov NCT05325346 · fetched Nov 12, 2026
- Phase I Study of VLX-1005 in Healthy SubjectsPHASE1 · COMPLETED · started Mar 24, 2021ClinicalTrials.gov NCT04783545 · fetched Nov 12, 2026